logo
Plus   Neg
Share
Email

Roche To Present New Data From Neuroscience Portfolio at 2019 AAN Annual Meeting

Swiss drug major Roche (RHHBY) said that it will present new data for its approved and investigational medicines for the treatment of neurological conditions at the 71st American Academy of Neurology Annual Meeting from 4-10 May in Philadelphia, PA.

Presentations will include data from a pivotal study of its investigational drug Risdiplam in spinal muscular atrophy, new data of its approved drug OCREVUS in relapsing and primary progressive multiple sclerosis, and that of its investigational medicines like Satralizumab in neuromyelitis optica spectrum disorder (NMOSD), RG6042 in Huntington's disease (HD), Gantenerumab and RO7105705 in Alzheimer's disease and RG6206 in Duchenne muscular dystrophy.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Swiss food giant Nestle SA said it is committed to achieving zero net greenhouse gas emissions by 2050, noting that climate change is one of the biggest threats faced by the world. As part of its efforts to achieve the goal, Nestle said it will launch more plant-based food and beverage options that are more environment friendly. Coffee giant Starbucks Corp. is set to open the world's largest Starbucks Reserve Roastery on November 15 on Chicago's Magnificent Mile. It will open in an interactive four-storey glass-clad building in 43,000 square feet space, employing about 200 people. The site at the corner of North Michigan Avenue and Erie Street was previously occupied by Crate & Barrel. United Parcel Service Inc. agreed to pay $8.4 million to the United States to settle allegations that it overcharged federal agencies for package delivery services, the U.S. Justice Department said. Under a General Services Administration or GSA contract, UPS was required to provide GSA with certain lower prices for its services.
Follow RTT